Webinar: EASL Update - FibroScan Applications in NAFLD-NASH

Echosens Webinar on NAFLDПодробнее

Echosens Webinar on Combined LSM and CAP Testing in Fatty Liver PatientsПодробнее

EASL Studio S4E12 - NAFLD and NASH – moving beyond the liver biopsy – where are we now?Подробнее

ILC 2021 Echosens webinar: Enhancing the management of NAFLD patients with FibroScan®-based Scores.Подробнее

What is NAFLD / NASH? The NASH Education Program™ - US Launching WebinarПодробнее

Echosens Webinar on NAFLD/NASHПодробнее

Webinar: EVOLVING DIAGNOSTIC STRATEGIES FOR NAFLD/NASHПодробнее

FLF LIVER Webinar Series | Part-One (Highlights from EASL 2020)Подробнее

Clinical Update on the Management of Fatty Liver Disease in T2DM PatientsПодробнее

ILC 2021 Press Conference 25 June - NAFLD / NASHПодробнее

Metabolomic Approaches in NASH and NAFLD R&D Webinar | Dec 2017Подробнее

EDDW2020_DAY2_International Webinar on (NAFLD Vs MAFLD Update)Подробнее

Clinical overview of NAFL/NASHПодробнее

EASL Policy Statement on the coexistence of NAFLD and ARLD (Patient Forum 2020)Подробнее

Fatty Liver Disease Webinar - July 2021Подробнее

Echosens Webinar - Pronostic value of FibroScan and FibroMeter in Chronic liver diseasesПодробнее

IRIA Webinar on Preventing NAFLD & NASH-Risk stratification with elastography in Fatty Liver diseaseПодробнее